As of the latest Form 4 filed Jul 2, 2026.
What Electromed Inc insiders — officers, directors and 10% owners — have bought and sold in their own stock, straight from their SEC Form 4 filings. Values are shares × the reported transaction price where both are disclosed.
Buys plotted up, sells down; bar height is the disclosed dollar value (shares × reported price). Our Form 4 history is only complete from mid-2026, so early months are sparse — the series fills in as more filings land. Open-market purchases and sales only.
Newest filing first — the 14 most recent filings for ELMD.
| Filed | Trade date | Insider | Transaction | Shares | Price | Value | 10b5-1 | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-07-02 | 2026-06-30 | Nagel Bradley M. Chief Financial Officer | FTax | −674.00 | $42.30 | $28.5K | No | Form 4 ↗ |
| 2026-06-09 | 2026-06-08 | Cunniff James L. CEO and President | SSale | −1.03K | $37.77 | $38.8K | No | Form 4 ↗ |
| 2026-06-09 | 2026-06-08 | Cunniff James L., CEO and President | SSale | −1.67K | $36.80 | $61.5K | No | Form 4 ↗ |
| 2026-06-09 | 2026-06-08 | Cunniff James L., CEO and President | SSale | −7.00K | $36.25 | $254K | No | Form 4 ↗ |
| 2026-06-09 | 2026-06-08 | Cunniff James L., CEO and President | MExercise | +9.70K | $17.25 | $167K | No | Form 4 ↗ |
| 2026-06-08 | 2026-06-04 | Nagel Bradley M. Chief Financial Officer | SSale | −181.00 | $37.11 | $6.72K | No | Form 4 ↗ |
| 2026-06-08 | 2026-06-04 | Nagel Bradley M., Chief Financial Officer | SSale | −11.6K | $36.34 | $422K | No | Form 4 ↗ |
| 2026-06-08 | 2026-06-04 | Nagel Bradley M., Chief Financial Officer | MExercise | +5.27K | $10.71 | $56.4K | No | Form 4 ↗ |
| 2026-06-08 | 2026-06-04 | Nagel Bradley M., Chief Financial Officer | MExercise | +4.33K | $10.25 | $44.4K | No | Form 4 ↗ |
| 2026-05-19 | 2026-05-15 | SKARVAN KATHLEEN Director | SSale | −3.56K | $37.33 | $133K | No | Form 4 ↗ |
| 2026-05-19 | 2026-05-15 | SKARVAN KATHLEEN, Director | SSale | −9.26K | $36.26 | $336K | No | Form 4 ↗ |
| 2026-05-19 | 2026-05-15 | SKARVAN KATHLEEN, Director | SSale | −19.0K | $35.24 | $671K | No | Form 4 ↗ |
| 2026-05-19 | 2026-05-15 | SKARVAN KATHLEEN, Director | SSale | −8.15K | $34.36 | $280K | No | Form 4 ↗ |
| 2026-05-19 | 2026-05-15 | SKARVAN KATHLEEN, Director | MExercise | +40.0K | $3.82 | $153K | No | Form 4 ↗ |
Insiders — a company’s officers, directors and holders of more than 10% of its stock — must report any trade in that stock to the SEC on a Form 4 within two business days. Each row here is one transaction from those filings.
The transaction code tells you what happened: Purchase (P) and Sale (S) are open-market trades — the ones markets watch most; Award (A) is a granted stock or unit, Option exercise (M) converts options into shares, and Gift (G) is a transfer for no consideration. Awards, exercises and gifts are largely compensation or administrative, not a directional bet.
One caveat on sales: many are made under a Rule 10b5-1 plan scheduled months in advance, so a sale is not automatically a bearish signal. Insider activity is a noisy input — read it alongside the filings, not on its own.
See also ELMD’s full analysis or the market-wide insider trading feed. The tabs above jump to ELMD’s other SEC data.
Source: SEC Form 4 filings for ELMD, parsed from EDGAR. Transaction prices are as reported in the filing — SEC public-domain data, not market quotes. Values are shares × reported price where both are disclosed; grants and gifts often carry no price. A delayed record of what insiders reported, not a live position or a recommendation.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.